IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality | Journal of Neurology, Neurosurgery & Psychiatry

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

JNNP 100

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Neuromuscular

Original research

IgG₁ pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality

Online download statistics by month:

Online download statistics by month: August 2021 to December 2022

	Abstract	Full	Pdf
Aug 2021	461	463	153
Sep 2021	668	675	227
Oct 2021	268	271	105
Nov 2021	161	163	105
Dec 2021	107	110	66
Jan 2022	176	176	105
Feb 2022	103	111	51
Mar 2022	139	141	65
Apr 2022	131	132	71
May 2022	166	161	77
Jun 2022	129	128	36
Jul 2022	118	115	49
Aug 2022	135	132	59
Sep 2022	95	98	48
Oct 2022	138	136	58
Nov 2022	132	131	56
Dec 2022	113	110	34
Total	3240	3253	1365